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Rotavirus nonstructural protein 4 (NSP4) is known to function as an intracellular receptor at the endo-
plasmic reticulum (ER) critical to viral morphogenesis and is the first characterized viral enterotoxin.
Exogenously added NSP4 induces diarrhea in rodent pups and stimulates secretory chloride currents across
intestinal segments as measured in Ussing chambers. Circular dichroism studies further reveal that intact
NSP4 and the enterotoxic peptide (NSP4114-135) that is located within the extended, C-terminal amphipathic
helix preferentially interact with caveola-like model membranes. We now show colocalization of NSP4 and
caveolin-1 in NSP4-transfected and rotavirus-infected mammalian cells in reticular structures surrounding the
nucleus (likely ER), in the cytosol, and at the cell periphery by laser scanning confocal microscopy. A direct
interaction between NSP4 residues 112 to 140 and caveolin-1 was determined by the Pro-Quest yeast two-
hybrid system with full-length NSP4 and seven overlapping deletion mutants as bait, caveolin-1 as prey, and
vice versa. Coimmunoprecipitation of NSP4–caveolin-1 complexes from rotavirus-infected mammalian cells
demonstrated that the interaction occurs during viral infection. Finally, binding of caveolin-1 from mammalian
cell lysates to Sepharose-bound, NSP4-specific synthetic peptides confirmed the yeast two-hybrid data and
further delineated the binding domain to amino acids 114 to 135. We propose that the association of NSP4 and
caveolin-1 contributes to NSP4 intracellular trafficking from the ER to the cell surface and speculate that
exogenously added NSP4 stimulates signaling molecules located in caveola microdomains.
Rotaviruses (RV) cause severe, life-threatening gastroenter-
itis in children and animals worldwide and in immunocompro-
mised and elderly adults (46). The RV genome is composed of
11 segments of double-stranded RNA that encodes five non-
structural and six structural proteins (17). Nonstructural pro-
tein 4 (NSP4), encoded by RV gene 10, initially was identified
as an endoplasmic reticulum (ER) transmembrane glycopro-
tein essential to RV morphogenesis by serving as an intracel-
lular receptor to double-layered particles (DLPs) (5, 44, 67,
66). NSP4 residues 161 to 175 bind the outer coat protein
(VP6) of the DLPs, which facilitates translocation into the ER
and the addition of two viral proteins, VP7 and VP4, and a
transient ER membrane (40, 66, 67); NSP4 is sufficient for the
budding of DLPs into the ER lumen (33). The ER transient
viral envelope is eventually removed by an unknown mecha-
nism prior to virus release (40, 44). Because the NSP4 se-
quence lacks classical ER retention signals and does not ap-
pear to be retrieved by retrograde transport and the two
N-linked, high-mannose glycosylation sites remain sensitive to
endoglycosidase H (endo H) digestion, the current tenet is that
NSP4 does not enter or traffic through the Golgi (5, 16).
In addition to facilitating RV maturation at the ER, NSP4
functions as the first described viral enterotoxin that induces
diarrhea in neonatal mice and rats in the absence of histolog-
ical alterations (3, 4). The enterotoxic region of NSP4 maps to
amino acids (aa) 114 to 135, as determined by functional stud-
ies of overlapping synthetic peptides (4). Exogenous addition
of intact NSP4 or the enterotoxic peptide NSP4114-135 to cul-
tured cells or mouse pup intestinal mucosa triggers a phospho-
inositide (PI) signal transduction pathway at the plasma mem-
brane (PM), resulting in the elevation of inositol trisphosphate,
intracellular calcium ([Ca2]i) mobilization, and chloride se-
cretion with fluid loss (11, 15, 41). Endogenous expression of
NSP4 or NSP4 fusion proteins likewise elevates [Ca2]i levels,
but by a distinct, phospholipase C-independent mechanism (6, 69).
The functions attributed to NSP4 expression continue to
expand. NSP4 and NSP4114–135 also affect the sodium-coupled
transport of D-glucose and L-leucine, as demonstrated with
intestinal brush border membrane vesicles from young rabbits
(24). These data suggest that NSP4 interacts with membrane
vesicles or vesicle-bound proteins to affect RV pathogenesis.
Other data show that NSP4 associates with Triton X-100 de-
tergent-resistant membranes during RV infection, indicating
that rafts or caveolae may be involved in NSP4 activity (52).
NSP4 has been reported to bind microtubules, block ER-to-
Golgi trafficking, and accumulate in microtubule-associated
membrane compartments (66, 74). The NSP4 microtubule
binding domain maps to the C-terminal 54 residues (129 to
175) (74). In addition, several studies report NSP4-specific
seroconversion of immunoglobulin A (IgA) and IgG in RV-
infected patients, indicating that NSP4 is exposed to immune
cells (51, 75, 76).
Hence, there is increasing evidence that NSP4 is not exclu-
sively localized at the ER but traffics from the ER by a pathway
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that likely bypasses the Golgi (5, 6, 7, 14, 43). Isolation of an
NSP4 cleavage fragment (aa 112 to 175) in culture medium of
infected cells further supports the release of endogenously
expressed NSP4 from the cell (77). The purified NSP4 frag-
ment initiates PI signaling events and fluid loss, presumably by
interacting with the host cell or neighboring cell surface recep-
tors (77). NSP4 also has been shown to interact with the ex-
tracellular matrix proteins laminin-3 and fibronectin at aa 87
to 145 by yeast two-hybrid assays and coimmunoprecipitation
(7). The authors suggest that NSP4 is basolaterally secreted
into tissues that underlie the enterocytes to interact with the
extracellular matrix.
Circular dichroism spectroscopic experiments demonstrate
that NSP4 and NSP4114-135 preferentially bind to highly
curved, anionic, cholesterol-rich model membrane vesicles that
mimic PM caveolae in lipid structure and content (25, 26). In
vivo, caveolae are a subset of lipid rafts that are highly curved
and rich in cholesterol and sphingomyelin and contain the
integral membrane protein caveolin-1 (2). Caveolae are found
in most cells, including those of the intestine (18), wherein
caveolin-1 forms a scaffold to organize signaling molecules at
the PM (2, 49, 54, 57, 63). Key molecular components of Ca2
regulation and signaling are localized to caveolae, including
Ca2 ATPase, inositol trisphosphate receptors, tyrosine ki-
nases, G proteins, and calmodulin (2, 21, 50, 53, 54). In addi-
tion, caveolae compartmentalize as much as 50% of cellular
phosphatidylinositol diphosphate (PIP2) (2, 21, 50, 53, 54) and
are the site of PIP2 hydrolysis in response to a ligand (50).
Given that NSP4 preferentially binds highly curved, anionic,
cholesterol-rich model membranes, promotes PIP2 hydrolysis
upon exogenous addition, and disrupts calcium homeostasis, it
is reasonable to propose that exogenously added NSP4 inter-
acts with molecules localized to caveola PM microdomains.
The interaction of NSP4 and caveolin-1 was examined by
four distinct approaches, (i) laser scanning confocal micros-
copy (LSCM), (ii) in vivo reverse yeast two-hybrid analyses,
(iii) coimmunoprecipitation of RV-infected cells, and (iv) in
vitro peptide binding assays. This study localized the caveolin-1
binding domain to an NSP4 region that overlaps other func-
tional domains, including the enterotoxic peptide. LSCM stud-
ies further revealed that NSP4 and caveolin-1 colocalize in
mammalian cells both in the presence and in the absence of
other rotavirus proteins.
MATERIALS AND METHODS
Antibodies. NSP4 and caveolin-1 peptide-specific antibodies were generated in
mice, rabbits, or rats as previously described and include mouse anti-NSP4120-147
and -NSP4150-175; rabbit anti-NSP42-22, -NSP4113-149, -NSP4120-147, -NSP4150-175,
and -caveolin-12-32; and rat anti-caveolin-1161-178 (25, 64). Rabbit anti-caveolin-1
was purchased from Jackson Immunoresearch Labs Inc. (West Grove, CA) or
Transduction Labs (San Diego, CA). Preimmune mouse, rat, and rabbit sera
were used as negative controls. Bound antibodies were detected by horseradish
peroxidase-labeled goat anti-rabbit or -mouse IgG (Kirkegaard & Perry Labo-
ratories, Inc., Gaithersburg, MD; Pierce, Rockford, IL; Rockland, Gilbertsville,
PA), fluorescein isothiocyanate (FITC)-conjugated goat anti-rabbit or -mouse
IgG (Kirkegaard & Perry Laboratories, Inc.), or Texas Red-conjugated goat
anti-rabbit IgG (Transduction Labs).
Mammalian cell lines. MDCK, Caco-2, and BSC-1 cells were obtained from
the American Type Culture Collection (Manassas, VA) and maintained in Dul-
becco modified Eagle medium (Gibco, Grand Island, NY) supplemented with
10% fetal bovine serum, L-glutamine (2 mM), penicillin-streptomycin (100 g/
ml), and nonessential amino acids (Sigma, St. Louis, MO). For confocal imaging
analyses, cells were grown on Lab-Tek chambered-cover glass slides (Nalge Nunc
International, Naperville, IL) or coverslips to 70% confluence. Due to the high
expression level of caveolin-1 in MDCK cells (this study), MDCK cell lysates
were prepared as a source of caveolin-1. Fischer rat thyroid (FRT) cells that lack
expression of caveolin-1 (1, 29) were a kind gift of E. Rodriguez-Boulan (Weill
Medical College of Cornell University, New York, NY) and were grown in Coons
F12 medium (Sigma) with 10% fetal bovine serum to 90% confluence. FRT
cell lysates served as a caveolin-1-negative mammalian cell control. All cells were
utilized prior to 100% confluence and differentiation.
Construction of mammalian plasmids. NSP4 cDNA initially was PCR amplified
from pcDNA2.1-NSP4 (gift of M. Estes, Baylor College of Medicine, Houston, TX);
the forward and reverse primers were 5-GATATCAAGATGGAAAAGCTTACC
GACC-3 and 3-TTCACTGACGACGTTACTAATTCGAA-5, respectively (the
underlined portions are a 3HindIII site and a 5EcoRI site). The PCR product was
inserted directly into the pcDNA3.1 Topo vector of the eukaryotic TOPO TA
cloning kit (Invitrogen, Carlsbad, CA) to generate pcDNA3.1-NSP4, transformed
and amplified in TOPO10 cells and sequence verified (Gene Technology Lab, Texas
A&M University).
Expression of NSP4 in transiently transfected and RV-infected mammalian
cells. MDCK, BSC-1, and Caco-2 cultured cells were transfected with
pcDNA3.1-NSP4 with Lipofectamine plus reagent (Gibco, BRL) according to
the manufacturer’s protocol and incubated at 37°C with 5% CO2 for 36 h.
Expression of NSP4 was verified by Western blot analysis and LSCM imaging
(see below).
To examine NSP4 expression in the context of a viral infection, MDCK cells
were plated at a density of 105 cells/cm2 on sterile glass coverslips, incubated at
37°C in 5% CO2 for 24 h, and then mock infected or infected with RV SA11 at
a multiplicity of infection (MOI) of 4 PFU/cell. At 20 h postinfection (hpi), the
cells were washed twice with phosphate-buffered saline (PBS), fixed, and per-
meabilized for 10 min with methanol-acetone (1:1, vol/vol) at 20°C and stained
for LSCM imaging (see below).
Western blot assays. Transiently transfected MDCK, Caco-2, and BSC-1 cells or
RV-infected MDCK cells were lysed in RIPA buffer (0.5% sodium deoxycholate,
10% NP-40, 150 mM NaCl, 50 mM Tris, pH 8.0, 0.1% sodium dodecyl sulfate [SDS])
containing the following protease inhibitors: 100 M 4-(2-aminoethyl)-bezenesulfo-
nylfluoride HCl (AEBSF), 80 nM aprotinin, 5 M bestatin, 1.5 M (2S,3S)-3-(N-
{(S)-1-[N-(4-guanidinobutyl)carbamoyl]3-methylbutyl}carbamoyl)oxirane-2-carbox-
ylic acid (E-64), 2 M leupeptin, 1 M pepstatin A, and 100 M phenylmethylsulfonyl
fluoride (PMSF) (Calbiochem-Novabiochem Corp., San Diego, CA). Proteins
were quantified by bicinchoninic acid assay (Pierce). All lysates were separated
by 12% SDS-polyacrylamide gel electrophoresis (PAGE), electroblotted onto
nitrocellulose membranes, and blotted with NSP4 peptide- or caveolin-1 peptide-
specific antibodies. Reactive bands were visualized by the addition of horseradish
peroxidase-conjugated IgG and SuperSignal West Pico chemiluminescent sub-
strate (Pierce), followed by exposure to Kodak X-Omat film (47).
LSCM analyses and colocalization. Before examining for colocalization of
NSP4 with caveolin-1, it was important to affirm the expression of caveolin-1 in
the cultured cells. Intestinal (Caco-2) and kidney (MDCK, BSC-1) epithelial cell
lines were sequentially probed with rabbit anti-human caveolin-1 (Transduction
Labs) and goat anti-rabbit-IgG–Texas Red, and the specific fluorescence was
monitored by LSCM.
Once caveolin-1 expression was established, pcDNA3.1-NSP4-transfected
MDCK, BSC-1, and Caco-2 cells were incubated for 48 h, fixed with methanol-
acetone (1:1, vol/vol) at 20°C, blocked with 3% BLOTTO (nonfat dry milk in
PBS), and incubated with mouse anti-NSP4120-147 (1:200) and rabbit anti-caveo-
lin-1 (1:500; Transduction Labs) to detect NSP4 and caveolin-1, respectively.
Goat anti-mouse IgG-FITC and goat anti-rabbit IgG-Texas Red were used to
detect the primary antibodies. RV- or mock-infected cells grown on glass cov-
erslips were similarly fixed and permeabilized with methanol-acetone (1:1, vol/
vol). The fixed cells were briefly air dried, rinsed in PBS, blocked in 3%
BLOTTO, and incubated with mouse anti-NSP4150-175 (1:600) and rabbit anti-
caveolin-1 (1:200). Goat anti-mouse IgG conjugated to Texas Red and goat
anti-rabbit IgG conjugated to FITC were then used to visualize the NSP4 and
caveolin-1 antibodies, respectively. All antibodies were diluted in 1% BLOTTO,
and incubations were followed with a minimum of four washes with 0.5%
BLOTTO, 10 min each. The coverslips were rinsed with PBS and affixed to glass
slides with fluorescence microscopy mounting medium (Kirkegaard & Perry
Laboratories, Inc.). To control for the specificity of the NSP4 antibody staining,
mock-transfected and mock-infected cells were stained with both primary and
secondary antibodies.
All cells were visualized with an MRC-124MP Bio-Rad LSCM with a Zeiss
Axiovert inverted microscope (Carl Zeiss, Inc., Thornwood, NY), a 63 oil
Apochromat objective, and the 488-nm excitation line of an argon-krypton ion
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laser source. The 523/DF35 nm and HQ598/40 filters were utilized to capture
FITC and Texas Red fluorescence, respectively, with the transfected cells. Typ-
ical settings were as follows: iris  2.0, laser power  1 to 3%, gain  1,000 to
1,250, and black level  6. The settings used with the virus-infected cells were
a 598/40-nm filter, an iris setting of 2.5, a gain of 1,230, and a low-signal boost for
Texas Red, while a 530/40-nm filter, an iris setting of 2.2, a gain of 1,230, and a
low-signal boost were used for FITC. A 30% power level setting was used in
addition to Kalman averaging (n  4) and a 3 digital zoom to refine the
subcellular fluorescence signals. To evaluate the extent to which the fluorescence
of the FITC and Texas Red panels colocalized in transfected and infected cells,
LaserSharp 3.0 (Bio-Rad) and Metamorph version 3.6 software (Universal Im-
aging Corp., West Chester, PA) were used to construct the images and fluoro-
grams from individual photomultiplier tube signals.
Pixel fluorograms from the Texas Red and FITC components were generated
for each set of data to minimize spectral bleedthrough of each signal into the
other channel (data not shown). In this way, overlapping pixels belonging to both
the Texas Red (red) and FITC (green) channels in the original image could be
selected and shown separately (see Fig. 3C, far right). This was accomplished by
calculation of the colocalization coefficients for each channel with the equations
Cgreen

i
I
g
i
	gr
i

i
I
g
i
Cred

i
I
r
i
	rg
i

i
I
r
i
where Cred and Cgreen are the colocalization coefficients, I r/i and I g/i represent
the red and green intensities of the ith pixel after background subtraction, and
	rg(i) and 	gr(i) are Kronecker deltas that represent intensity-independent colo-
calization weights (36, 39).
Note that for every ith pixel, 	rg(i)  	gr(i)  0 if only a red intensity or a green
intensity exists but not both, whereas 	rg(i)  	gr(i)  1 only if both a red and a
green intensity are associated with the ith pixel. Hence, a coefficient indicates the
fraction of the total intensity that is colocalizing with both fluorescent probes.
Yeast two-hybrid screening. The ProQuest two-hybrid system (Invitrogen) was
used to identify potential interactions of NSP4 and caveolin-1. Saccharomyces
cerevisiae strain MaV203 (MAT leu2-3,112 trp1-901 his3200 ade2-101 gal4
gal80 SPAL10::URA3 GAL1::lacZ HIS3UASGAL1::HIS3 LYS2 Can1r Cyh2r) was
used for all two-hybrid analyses (71, 72). A collection of yeast strains that contain
plasmid pairs expressing fusion proteins with a spectrum of interaction strengths
{pPC97 [GAL4 DNA-binding domain (DBD), LEU2], pPC97-CYH2S, and
pPC86 [GAL4 activating domain (AD), TRP1] } were used as controls (22, 30,
71, 72). Control plasmids pDBleu and pEXP-AD507 contain only the GAL4
DBD and the GAL4 AD, respectively. A series of yeast transformations were
performed to determine the efficiency of the transformation protocol and to test
the individual plasmid efficiency of transformation (data not shown).
NSP4 and caveolin-1 yeast constructs. All plasmid manipulations were per-
formed according to standard protocols with Escherichia coli DH5 as described
in the Gateway System manual (2a). Overlapping NSP4 N-terminal (nucleotides
[nt] 135 to 528, nt 304 to 528, and nt 336 to 528), C-terminal (nt 1 to 321 and nt
1 to 450), and combined N- and C-terminal (nt 240 to 420 and nt 270 to 450)
deletion mutations were PCR amplified from pcDNA3.1-NSP4 with the forward
and reverse primers depicted in Fig. 1. Caveolin-1 was amplified from pCCaveo-
lin-1 (a gift from R. Anderson, Southwestern Medical School, Dallas, TX) with
forward primer BP12 (5-ATGTCTGGGGGCAAATA-3) and reverse primer
BP13 (5ATATCTCGAGTTATATTTCTTTCTGCAAGTTGAT-3 [the under-
lined sequence is a 3 XhoI site]). The PCR products were directionally cloned
into Gateway System entry vector pENTR11 (Invitrogen), sequence verified,
subcloned into the destination vectors of the Gateway Expression System, pD-
EST22 ([AD]-X) and pDEST32 ([DBD]-Y), and transformed into MaV203 (2a).
Briefly, 300 ng of the pENTR11-NSP4/caveolin-1 plasmids was incubated with
300 ng of the linearized destination vector pDEST22 or pDEST32, LR buffer,
FIG. 1. Linear schematic of RV SA11 full-length NSP4 and deletion mutants with forward and reverse primers. PCR fragments were generated
with the forward and reverse primers listed to the right of each construct and were cloned into DBD plasmid pD22 and AD plasmid pD32 of the
ProQuest yeast two-hybrid system with Gateway technology. The NSP4 full-length clone of 528 nt was subjected to specific deletions to construct
two 3 deletion mutants, nt 1 to 321 and nt 1 to 450; three 5 deletion mutants, nt 135 to 528, nt 304 to 528, and nt 336 to 528; and two 5 and
3 deletion mutants, nt 240 to 420 and nt 270 to 450.
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Tris-EDTA (1), and the LR Clonase enzyme mix (Invitrogen). The resultant
clones were transformed into DH5 and plated onto Luria-Bertani plates
with 100-g/ml ampicillin or 7-g/ml gentamicin. Following amplification,
recombinant plasmids were extracted with the Wizard miniprep kit (Promega,
Madison, WI); restriction enzyme digested with EcoRV, KpnI, or XhoI
(Promega); and sequence verified as pDEST22- and pDEST32-NSP4 or
-caveolin-1. Both fusion proteins were individually transformed into S. cer-
evisiae MaV203 to test each clone for self-activation and determine the
concentration of 3-amino-1,2,4-triazole (3AT) required to titrate basal HIS3
expression levels.
Yeast two-hybrid assay. To screen for NSP4 and caveolin-1 interactions, two
sets of bait (GAL4 DBD) and prey (GAL4 AD) fusion proteins were assayed as
DBD–caveolin-1 with AD-NSP4 and as DBD-NSP4 with AD–caveolin-1. Yeast
strain MaV203 was transformed by a modified lithium acetate procedure as
previously described (22). Transformants were grown at 30°C for 3 days on
complete synthetic medium lacking leucine and tryptophan (CSM-Leu Trp)
and replica plated onto the following media to determine the induction of the
reporter genes URA3, HIS3, and lacZ: CSM-Leu Trp  Ura, CSM-Leu Trp
plus 0.2% 5-fluoroorotic acid (5FOA), and CSM-Leu Trp His plus 3AT
(12.5, 50, and 100 mM 3AT).
-Gal assays. For qualitative measurement of -galactosidase (-Gal) expres-
sion, transformed yeast was plated onto yeast-peptone-adenine-dextrose medium
plates containing a nitrocellulose filter. The presence of -Gal was detected by
the addition of X-Gal (5-bromo-4-chloro-3-indolyl--D-galactopyranoside). To
quantitatively measure -Gal activity, chlorophenol red--D-galactopyranoside
(CPRG) was used as the substrate (2a).
Yeast fusion protein detection. Fusion protein expression levels were moni-
tored by Western blotting. Yeast protein extracts were prepared with the Zymo
yeast protein extraction kit (Zymo Research, CA). Briefly, cells were grown in
yeast-peptone-adenine-dextrose medium overnight at 30°C and 106 cells were
pelleted and resuspended in Y-Lysis buffer with Zymolyase for 1 h at 37°C. The
cells were pelleted again and resuspended in PBS, pH 7.2, containing protease
inhibitors (100 M AEBSF, 80 nM aprotinin, 5 M bestatin, 1.5 M E-64, 2 M
leupeptin, 1 M pepstatin A, and 100 M PMSF), and protein was quantified by
bicinchoninic acid assay. Equivalent amounts of protein were loaded onto 12%
SDS-PAGE gels for Western blot analysis as described above.
Coimmunoprecipitation and endoglycosidase treatment. MDCK cells were
grown as described above and infected with RV SA11 at an MOI of 2 PFU/cell.
At 24 hpi, infected and noninfected monolayers were harvested with equal
volumes of SDS-free RIPA buffer. Equal volumes of lysates were immunopre-
cipitated with rat anti-caveolin-1161-178 or rat preimmune serum, followed by the
addition of protein G-agarose (6% slurry diluted 1:25; Pierce). The agarose
beads were pelleted and boiled in sample reducing buffer, and equal volumes
were separated by SDS-PAGE and electrotransferred to nitrocellulose mem-
branes. The membranes were blotted with rabbit anti-NSP4150-175 and horserad-
ish peroxidase-conjugated goat ant-rabbit IgG. Antibody-specific proteins were
visualized by chemiluminescence (described above).
To ensure that the multiple immunoreactive bands were NSP4 specific, unin-
fected (control) and RV-infected MDCK cell lysates were treated with endo H.
Briefly, glycoprotein denaturing was completed in accordance with the manu-
facturer’s (New England Biolabs, Ipswich, MA) directions. Samples were then
mock treated or digested with endo H for 1 h at 37°C. The treated lysates were
resolved by SDS-PAGE, electrotransferred to nitrocellulose, and probed with
NSP4-specific antibody in a Western blot assay. Any shift in NSP4 molecular
weight due to glycosidase treatment was visualized by chemiluminescence as
described above.
In vitro binding assay. To confirm a direct NSP4–caveolin-1 interaction, syn-
thetic peptides corresponding to NSP4113-149, NSP4114-135, and NSP42-22 were
attached to cyanogen bromide-activated Sepharose 4B beads as recom-
mended by the manufacturer (Amersham Biosciences Corp., Piscataway, NJ).
MDCK or FRT cell lysates (100 g of protein) were mixed with 50 l of a
50% slurry of Sepharose 4B- or Sepharose 4B-NSP4 peptide-bound beads
and rotated overnight at 4°C. The beads were pelleted by centrifugation,
thoroughly washed, and resuspended in PBS containing protease inhibitors
(100 M AEBSF, 80 nM aprotinin, 5 M bestatin, 1.5 M E-64, 2 M
leupeptin, 1 M pepstatin A, 100 M PMSF). Equivalent amounts of all
samples were separated by 12% SDS-PAGE, electrically transferred to ni-
trocellulose membranes, and blotted with caveolin-1-specific antibodies (see
above, Western blot assay). Negative controls and experiments included FRT
cell lysates, NSP42-22-Sepharose-bound beads, and Sepharose beads alone.
RESULTS
NSP4 is transiently expressed in mammalian cells. To verify
the transient expression of NSP4 in kidney BSC-1 and MDCK
cells and intestinal Caco-2 cells, each cell line was transfected
with pcDNA3.1-NSP4, grown for 36 h posttransfection, and
analyzed by Western blot assay with rabbit anti-NSP4120-147.
An NSP4-specific band at 28 kDa was present in all three cell
lines, indicating the expression of fully glycosylated, full-length
NSP4 (Fig. 2 lanes 2, 4, and 6). The intestinal Caco-2 cells also
revealed the mono- and unglycosylated forms of NSP4 (Fig.
2A, lane 4) (see below for endoglycosidase treatment). Un-
transfected lysates failed to react with the antibody (Fig. 2,
lanes 1, 3, and 5).
To evaluate the intracellular location of NSP4 in the absence
of other viral proteins, cells were grown in eight-well chamber
slides, transfected with pcDNA3.1-NSP4, fixed, and probed
sequentially with rabbit anti-NSP4120-147 and goat anti-rabbit
IgG-FITC. Use of LSCM to monitor the fluorescence signal
showed that all of the cell lines (Caco-2, MDCK, and BSC-1)
demonstrated comparable levels of NSP4 expression at multi-
ple locations in the cell (Fig. 3A). Reactivity with the NSP4
C-terminal peptide-specific antibody (residues 150 to 175) lo-
calized NSP4 to reticular structures surrounding the nucleus,
presumably the ER based on previous studies (5, 44, 66, 67),
but also to the cytoplasm and at the cell periphery. Primary and
secondary antibody controls displayed no background fluores-
cence (Fig. 3A, left). Although each of the cell lines showed
ample NSP4 expression, cytoplasmic vesicle-like structures
were most evident in the Caco-2 and MDCK cells (Fig. 3A,
cells on the left and in the center), whereas fluorescence near
the cell periphery was more pronounced in the MDCK and
BSC-1 cell lines (panel A, center and right). The BSC-1 cells
(panel A, right) were magnified twofold over the transfected
Caco-2 and MDCK cells to facilitate observation of the fluo-
rescent staining distribution. These data clearly demonstrate
that NSP4 is present outside of the ER and concur with the
punctate staining noted by Berkova et al. (6).
NSP4 and caveolin-1 colocalize. Earlier circular dichroism
data suggest that NSP4 and NSP4114-135 interact with caveola-
like membranes (25, 26). To further explore the possible in-
teraction(s) of NSP4 and caveolae in mammalian cells, colo-
FIG. 2. Transient expression of NSP4 in mammalian cells. BSC-1,
Caco-2, and MDCK cells were transiently transfected with pcDNA3.1-
NSP4 as described in Materials and Methods. Equal protein concen-
trations of lysates were separated by 12% SDS-PAGE and electro-
transferred to nitrocellulose for Western blot analyses. A specific band
for full-length, fully glycosylated NSP4 at 28 kDa was observed in all
three cell lines when probed with rabbit anti-NSP4120-147 (lanes 2, 4,
and 6). The Caco-2 cells also showed monoglycosylated and unglyco-
sylated, full-length NSP2 (lane 4). Untransfected cell lysates did not
show any NSP4-specific bands (lanes 1, 3, and 5).
VOL. 80, 2006 ROTAVIRUS NSP4 INTERACTS WITH CAVEOLIN-1 2845
 o
n
 February 27, 2015 by guest
http://jvi.asm.org/
D
ow
nloaded from
 
calization of NSP4 and caveolin-1, the structural protein of
caveolae, was evaluated by LSCM. Before the colocalization
study was implemented, it was important to confirm the ex-
pression and distribution of caveolin-1 in each cell line. Caco-2,
MDCK, and BSC-1 cells were seeded on chamber slides,
probed with caveolin-specific antibody, and examined by
LSCM. All of the tested cell lines were positive for caveolin-1
in the order of MDCK  Caco-2  BSC-1 based on pixel
intensity (data not shown). In addition, the distribution of
caveolin-1 at the PM, at the ER, and in the cytoplasm was
similar to that previously reported (2, 48, 55). Because of their
intestinal origin, the colocalization results of pcDNA3.1-NSP4-
transfected Caco-2 cells are shown (Fig. 3B). Mouse anti-
NSP4120-147 and goat anti-mouse IgG-FITC again localized
NSP4 to perinuclear structures (ER), the cytosol, and the cell
periphery (Fig. 3B, center). When the same cells were probed
with rabbit anti-caveolin-1 and goat anti-rabbit IgG-Texas
Red, caveolin-1 was localized to reticular and vesicular struc-
tures, in the cytosol, and at caveolae (panel B, left), as previ-
ously shown (2, 48, 55).
FIG. 3. Confocal imaging and colocalization of NSP4 and caveolin-1. (A) Detection of NSP4 in transiently transfected mammalian cells. Caco-2
(left), MDCK (center), and BSC-1 (right) cultured cells were transfected with pCDNA3.1-NSP4 and probed sequentially with rabbit anti-NSP4120-147
and goat anti-rabbit IgG-FITC. The cells were viewed by LSCM with a 63 Apochromat oil immersion objective. NSP4 was detected surrounding
the nucleus, in vesicular structures in the cytosol, and at the cell periphery. Primary and secondary antibody controls lacked background
fluorescence (far left). The BSC-1 cells (far right) are magnified twofold over the Caco-2 and MDCK cells to more easily view the subcellular
staining distribution. (B) Colocalization of NSP4 and caveolin-1. Caco-2 cells were transfected with pcDNA3.1-NSP4, grown for 36 h, and fixed
with methanol-acetone. Mouse anti-NSP4120-147 and rabbit anti-caveolin-1 were used to probe for NSP4 and caveolin-1, respectively, in the same
cells. Goat anti-mouse IgG conjugated to FITC and goat anti-rabbit IgG conjugated to Texas Red were used to detect the primary antibodies. Cells
were visualized by LSCM with a laser source of 488 and 568 nm. The leftmost panel shows the detection of caveolin-1 (Texas Red) with the Em/Filter
 HQ598/40, iris  2; the next panel shows detection of NSP4 (FITC) with Em/Filter  523/DF35. The third panel depicts the merged Texas Red
and FITC fluorescence images, and the rightmost panel shows the colocalization of caveolin-1 and NSP4 as determined with Universal Imaging
Metamorph software, version 3.6. Fluorograms were generated (not shown) and revealed 65% colocalization of NSP4 and caveolin-1. (C) RV-
infected MDCK cells were similarly probed and analyzed for caveolin-1 and NSP4 colocalization. As in panel B, caveolin-1 fluorescence is shown
on the left, followed by NSP4 and then the merged and colocalized images. For visualization of the infected cells, the settings were a 598/40-nm filter,
iris  2.5, for Texas Red and a 530/40-nm filter, iris  2.2, for FITC. Fluorograms generated by Metamorph software, version 3.6, disclosed that
73% of the caveolin-1 colocalized with NSP4 in RV-infected cells (data not shown).
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Metamorph program analyses revealed extensive (65%)
colocalization of NSP4 with caveolin-1 (Fig. 3B, right, n 5) in
transfected cells. To more readily distinguish colocalizing pix-
els and the intracellular distribution, fluorograms were gener-
ated (not shown), overlapping pixels were selected, and those
pixels were visualized (panel B, far right). These data showed
extensive colocalization between NSP4 and caveolin-1 in sub-
cellular domains previously shown to contain caveolin-1, i.e.,
ER, cytosolic vesicles, and caveola microdomains.
To establish that NSP4 colocalizes with caveolin-1 during
RV infection, the experiment was repeated with minor varia-
tions (see Materials and Methods). A single cell was selected
and magnified to enhance visualization of the fluorescent sig-
nals. As shown in Fig. 3C (far right), NSP4 colocalized with
caveolin-1 in infected MDCK cells. With an MOI of 4 PFU/
cell, NSP4 appeared more peripheral in the cell at 20 hpi
compared to the transfected cells. Computer analyses showed
that73% of caveolin-1 and NSP4 colocalized (n 13), some-
what higher than the percentage seen with the transfected
cells. Fluorograms were generated to more readily select those
pixels that overlapped, i.e., were excited by the FITC and Texas
Red probes at equivalent intensities (Fig. 3C, far right). As
with the transfected cells, extensive colocalization of NSP4 and
caveolin-1 was seen in RV-infected cells. Because peptide-
specific antibodies were utilized, the colocalization may in-
clude both the C terminus of the cleavage fragment (77) and
full-length NSP4.
NSP4 interacts with caveolin-1 in a yeast two-hybrid assay.
LSCM colocalization studies can place proteins within the
same organelle of a cell (within 200 nm) but are not sufficient
to verify a protein-protein interaction (27). Therefore, the Pro-
Quest Two-Hybrid System was utilized to determine if NSP4
and caveolin-1 directly interact. The sequences encoding NSP4
and caveolin-1 were cloned into yeast two-hybrid vectors
pDEST32 and pDEST22 to produce fusion proteins encoding
the GAL4 DBD fusion protein (the prey) and AD fusion
protein (the bait), respectively. The plasmids were cotrans-
formed into MaV203 and grown on complete synthetic me-
dium plates lacking leucine and tryptophan (CSM-Leu Trp)
with transformation efficiencies of 2  106 to 5  106 trans-
formants/g of plasmid DNA, typical of yeast cotransforma-
tions (22). To determine the extent to which the active tran-
scription factor for GAL4 was reconstituted by forming dimers
between the two fusion proteins, yeast cells were monitored for
growth on selective media (Fig. 4). Four phenotypes, His
(3ATr), -Gal, Ura, and 5FOAs, were used to assess the
activation of the chromosomally integrated His3, Ura3, and
-Gal reporter genes. As shown by the representative growth
patterns (Fig. 4), all of the transformants and the control yeast
FIG. 4. Representative growth patterns of cotransformed yeast in the reverse yeast two-hybrid assay. MaV203 cells were cotransformed with
pDest22caveolin-1 (DBD–caveolin-1) and pDest32NSP4 or pDestNSP432 mutants (AD-NSP4), and growth phenotypes were compared to those
of three yeast control strains, negative, weak interaction (1), and moderate interaction (2) (top three rows). Individual transformants,
pD32NSP4 80-140 (NSP4 nt 240 to 420), pD32NSP4 90-150 (nt 270 to 450), and pD32NSP4 1-175 (nt 1 to 528), were grown on CSM-Leu Trp
(far left column). Control and test colonies were replica plated onto (i) CSM-Leu Trp His plus 3AT at 12.5, 50, or 100 mM; (ii) CSM-Leu
Trp Ura; and (iii) CSM-Leu Trp plus 0.2% 5FOA. Growth on CSM-Leu Trp and CSM-Leu Trp His with 50 mM 3AT with little
to no growth on CSM-Leu Trp plus 0.2% 5FOA was considered a weak positive interactor. A moderate positive interaction was indicated by
growth on CSM-Leu Trp Ura, decreased growth on CSM-Leu Trp plus 0.2% FOA (far right panels), and inhibition of growth on
CSM-Leu Trp His with 50 mM 3AT. The stronger the interaction, the greater the growth on the CSM-Leu Trp Ura plates while the
growth on CSM-Leu Trp plus 0.2% FOA was significantly decreased.
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grew on CSM-Leu Trp plates, confirming the presence of
pDest32NSP4 and pDest22caveolin-1 or the control plasmids.
Overall growth patterns on selective media were evaluated
and compared to known phenotypes (2a). Induction of the
HIS3 gene was shown by dose-dependent growth inhibition on
CSM-Leu Trp His plus 3AT (12.5 mM, 50 mM, and 100
mM). Decreased growth with increased 3AT was seen, indic-
ative of a positive interaction. A basal level of His3 was pro-
duced at the lowest 3AT concentration, 12.5 mM, except for
the strong 2 positive control and NSP490-150 (Fig. 4). As
expected, the negative control yeast cells were not inhibited by
any of the concentrations of 3AT and showed growth (Fig. 4).
To further demonstrate the interaction of NSP4 and caveo-
lin-1, URA3 induction was evaluated by (i) growth on plates
containing CSM-Leu Trp Ura and (ii) inhibition of growth
on plates containing CSM-Leu Trp plus 0.2% 5FOA. URA3
has a weak promoter sometimes producing an intermediate
level of URA3 expression, resulting in both growth on CSM-
Leu Trp plus 0.2% 5FOA and no growth on plates lacking
uracil (2a). Growth patterns for both full-length NSP4 and all
seven mutant forms (Fig. 1) with caveolin-1 were evaluated in
this manner (Table 1). In addition, induction of lacZ was mea-
sured qualitatively for the presence of -Gal (X-Gal) and
quantitatively for -Gal activity (CPRG). Full-length NSP4
and the 1 positive control produced 0.29 and 0.26 U of -Gal
activity, respectively, whereas the negative control essentially
produced no -Gal activity (Table 1, column 7). As the NSP4
N-terminal hydrophobic domains of NSP4 were removed,
there was a progressive increase in -Gal activity compared to
full-length NSP4. This may reflect the different abilities of the
fusion proteins to cross the nuclear membrane; i.e., constructs
containing one or more of the three NSP4 N-terminal hydro-
phobic domains may be more readily retained in the mem-
branes of the yeast. This coincides with the -Gal activity
increasing from 0.29 to 2.20 U as additional hydrophobic res-
idues were deleted from the N terminus (Table 1).
Yeast transformed with pD32NSP4 corresponding to aa 1 to
150, aa 80 to 140, aa 90 to 150, aa 46 to 175, aa 101 to 175, and
aa 112 to 175 and pD22caveolin-1 demonstrated the positive
phenotype His (3ATr) Ura/ 5FOAs -Gal on the selec-
tion media (a total of 350 colonies from 12 yeast transforma-
tions), whereas NSP4 aa 1 to 107 produced the negative phe-
notype Ura 5FOAr -Gal (Table 1).
To verify that the positive interactions were due to the pres-
ence of NSP4 and caveolin-1, GAL-4 fusion proteins were
probed with NSP4-specific peptide antibodies or anti-caveolin-
12-32 (Fig. 5). Untransformed MaV203 (Fig. 5 lanes 1, 3, 6, 8,
and 11) was negative when blotted with all four antibodies. As
shown in Fig. 5, all NSP4 (panels A to C) and caveolin-1 (panel
D) fusion proteins were expressed and reactive to peptide-
specific antisera. The caveolin-1 fusion protein appeared as a
dimer in the same cotransformed yeast cell lysates (panel D).
Alignment of the positive and negative interactors revealed the
binding site of NSP4 to caveolin-1 to be between NSP4 aa 112
and 140.
NSP4 and caveolin-1 coimmunoprecipitate from RV-in-
fected cells. We then evaluated if the NSP4–caveolin-1 inter-
action occurred in RV-infected mammalian cells. At 24 hpi,
RV-infected and uninfected MDCK cells were lysed in SDS-
free buffer and immunoprecipitated with rat anti-caveolin-1161-178
or preimmune rat antisera. Subsequent Western blot analyses
with rabbit anti-NSP4150-175 revealed that NSP4-specific bands
precipitated from the infected cell lysates with anti-caveolin-1
(Fig. 6A, lane 4). An approximately 30-kDa band was detected
in the uninfected lysate control (panel A, lane 2) and was
considered a nonspecific background band. The molecular
weights of the precipitated bands were the same as those found
in RV-infected MDCK cell lysates that had not been reacted
with anti-caveolin-1 (panel A, lane 3). There were no NSP4-
specific bands detected by Western blot analysis in RV-in-
fected cell lysates precipitated with preimmune serum (panel
A, lane1).
Endo H digestions of the infected and uninfected MDCK
cell lysates were evaluated by Western blot analyses. A shift in
molecular weight verified that the multiple bands seen in RV-
infected cells are NSP4 specific, varying only in glycosylation
(Fig. 6B). Precipitation of the doubly glycosylated, singly gly-
cosylated, and unglycosylated forms of NSP4 (28-, 24-, and
20-kDa bands) with caveolin-1 antibody suggests that glycosy-
lation is not critical for the protein-protein interaction (5, 16).
The 15- and 18-kDa bands may represent cleavage fragments
of NSP4 or multimers of the 7-kDa cleavage product (77).
TABLE 1. Phenotypes of pD32-NSP4mutants plus pD22-caveolin-1a
Peptide CSM-Leu

Trp
CSM-Leu Trp His 3AT CSM-Leu Trp
Ura
CSM-Leu Trp 
0.2% 5FOA
-Gal
activity
(CPRG)
Phenotypec
12.5 mM 50 mM 100 mM
Negative control       0.07 Negative
1 positive control       0.26 Positive
2 positive control       2.44 Positive
NSP4 80-140       2.20 Positive
NSP4 90-150       2.17 Positive
NSP4 1-175       0.29 Positive
NSP4 1-150       0.42 Positive
NSP4 1-107       0.06 Negative
NSP4 46-175       1.39 Positive
NSP4 101-175       0.36 Positive
NSP4 112-175       0.70 Positive
a Colonies were grown on CSM-Leu Trp and were replica plated onto CSM-Leu Trp His with 12.5, 50, or 100 mM 3AT; CSM-Leu Trp Ura; and
CSM-Leu Trp with 0.2% 5FOA.
b -Gal expression was qualitatively monitored by using X-Gal (not shown), and -galactosidase activity was quantitatively measured by CPRG assay.
c The phenotype was determined by combining the results from the differential media.
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Although further analyses are needed to distinguish the com-
position of these bands, these data confirm the interaction of
NSP4–caveolin-1 during RV infection of mammalian cells.
NSP4113-149 and NSP4114-135 peptides capture caveolin-1
from MDCK cell lysates. An in vitro binding assay with NSP4-
specific synthetic peptides linked to Sepharose beads was de-
veloped to confirm the NSP4 caveolin-1 binding domain (aa
112 to 140) determined by yeast-two-hybrid analysis. The
Sepharose beads bound to NSP4113-149, NSP4114-135, or
NSP42-22 were incubated with MDCK or FRT cell lysates over-
night at 4°C, pelleted, thoroughly washed, separated by 12%
SDS-PAGE, and examined by Western blot assay. MDCK cell
lysates alone served as the positive control for caveolin-1 an-
tibody reactivity and showed a caveolin-1-specific band at 22
kDa (Fig. 7, lane 3 in panels A and B; lane 5 in panel C, and
lane 4 in panel D). MDCK cell lysates were reacted with beads
alone (no bound peptide) to rule out nonspecific binding of
caveolin-1 to the Sepharose beads (Fig. 7, lane 1 in panels A
and B and lane 2 in panel C). A caveolin-1-specific band at22
kDa was detected when MDCK cell lysates were reacted with
NSP4113-149 (panel A, lane 2). These data agree with the yeast
two-hybrid results delineating NSP4 aa 112 to 140 as the bind-
ing site for caveolin-1. A positive reaction also was obtained
with NSP4114-135 (Fig. 7B, lane 2), narrowing the caveolin-1
binding domain to NSP4 aa 114 to 135, the same 21 residues of
the enterotoxic peptide (4). In contrast, the NSP42-22 peptide
failed to capture caveolin-1 from MDCK cells (panel C, lane
3). FRT cell lysates, deficient in caveolin-1 expression, dem-
onstrated no binding to the NSP4 peptide-bound or unbound
beads (lanes 1 and 4 in panel C and lanes 2 and 3 in panel D).
In agreement with earlier studies (1, 29), FRT cell lysates were
negative for caveolin-1 by Western blot assay (panel D, lane 2).
These results complement the data obtained from the in vivo
yeast two-hybrid assay and further define the NSP4 binding site
of caveolin-1 to the enterotoxic peptide.
DISCUSSION
The results of this study show an interaction between the RV
enterotoxin NSP4 and the caveola structural protein caveolin-1
by yeast two-hybrid analyses, coimmunoprecipitation of in-
fected cell lysates, and an in vitro peptide capture assay. Con-
focal imaging colocalized NSP4 and caveolin-1 at multiple sites
in transfected and infected mammalian cells. To our knowl-
edge, this is the first study demonstrating the colocalization
and direct interaction of NSP4 and caveolin-1 and the first
identification of the caveolin-1 binding domain in the C-termi-
nal region of NSP4. These data corroborate and extend our
previous work showing that purified NSP4 and the enterotoxic
peptide NSP4114-135 bind to small unilamellar vesicles (SUVs)
with high membrane curvature that are caveola like in compo-
sition (25, 26). In that earlier report, we suggest that the NSP4-
caveola interaction is lipid mediated as the NSP4 and NSP4114-135
helical structures are stabilized by cholesterol and SUVs are
exclusively lipid in composition. The preference for negatively
charged phospholipids indicates an electrostatic component to
the NSP4-lipid vesicle interaction (25, 26). However, a more
mobile packing and lower surface pressure of the phospholip-
ids in the outer leaflet compared to the inner leaflet result in an
exposed hydrophobic core that may facilitate additional hydro-
phobic interactions (34, 65). Thus, the interaction is likely
more complex than first realized and possibly includes both
protein-lipid and protein-protein constituents. It would be in-
FIG. 5. Western blot analyses of yeast cell lysates cotransformed with full-length NSP4– or NSP4 mutant–caveolin-1 fusion protein. To verify
the expression of both the NSP4- and caveolin-1 fusion proteins, the cotransformed MaV203 yeast cell lysates were separated by 12% SDS-PAGE,
transferred to nitrocellulose membranes, and probed with rabbit anti-NSP42-22 (lanes 1 and 2), anti-NSP4150-175 (lanes 3 to 7), or anti-NSP4113-149
(lanes 8 to 10) for NSP4 or NSP4 mutants and anti-caveolin-12-32 (lanes 11 to 17) for caveolin-1. Untransformed controls are shown in lanes 1,
3, 6, 8, and 11.
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teresting to determine if the addition of caveolin-1 to choles-
terol-rich SUVs would enhance NSP4 binding.
NSP4 and caveolin-1 were colocalized within 200 nm in
transiently transfected and RV-infected mammalian cells.
Strong staining was observed in the juxtanuclear region and
peripheral sites in both transfected and infected cells. Caveo-
lin-1 staining was similar to that observed in previously re-
ported studies, predominantly in cell surface caveolae with
additional staining in juxtanuclear reticular structures (ER,
Golgi) and in the cytosol associated with either vesicles or
soluble complexes (2, 48, 49, 56). Hence, NSP4 peripheral
staining that colocalizes with caveolin-1 is potentially within
200 nm of the caveolin-1-containing PM caveolae. Evaluation
of the NSP4–caveolin-1 complex immunoprecipitated from
RV-infected MDCK cells with anti-caveolin-1 revealed fully
glycosylated, monoglycosylated, and unglycosylated forms of
NSP4, as confirmed by endo H digestion. In addition, an 15-
kDa cleavage fragment of NSP4 was precipitated that may be
a dimer of the reported 7-kDa cleavage fragment (77). These
data indicate that NSP4–caveolin-1 binding is independent of
glycosylation. However, glycan chains can induce local changes
in protein structure and dynamics, in particular in receptor
binding, and thus the role of glycosylation warrants further
investigation (35).
A panel of deletion mutant forms of NSP4 was utilized in the
yeast two-hybrid assay to map the NSP4–caveolin-1 binding
site to NSP4 aa 112 to 140. This is consistent with the physical
data reporting an amphipathic alpha-helical coiled-coil region
in the extended C-terminal cytoplasmic domain of NSP4 that
could serve as a potential binding site for other molecules (8,
44, 68). Using NSP4-specific peptides to capture caveolin-1
from MDCK cell lysates, an in vitro binding assay confirmed
the aa 112-to-140 binding domain and further delineated the
binding site to NSP4 residues 114 to 135, as summarized in Fig. 8.
FRT cell lysates lacking caveolin-1 were utilized as a control
and failed to bind NSP4 peptides. However, it is possible that
NSP4 binds a caveolin-1-associated molecule that is expressed
in MDCK cells but not FRT cells.
Previous data show that NSP4 and the enterotoxic peptide
are less structured when cholesterol is removed from model
FIG. 6. Coimmunoprecipitation of caveolin-1 and NSP4 from RV-infected MDCK cells. (A) RV-infected (lane 4) and uninfected (lane 2) MDCK
cell lysates were reacted with rat anti-caveolin-1161-178 and protein G-agarose. The infected MDCK cell lysates were also reacted with rat
preimmune sera, which served as a negative control (lane 1). All samples were separated by SDS-PAGE, transferred to nitrocellulose, and blotted
with anti-NSP4150-175. (A) The absence of NSP4-specific bands from infected MDCK cell lysates precipitated with preimmune serum and
uninfected cell lysates reacted with rat anti-caveolin-1161-178 are shown in lanes 1 and 2, respectively. Lane 3 contains RV-infected cell lysates alone
and serves as the positive control. Full-length, fully glycosylated, monoglycosylated, and unglycosylated NSP4 are present in lanes 3 and 4.
Additional bands at 18 and 15 kDa are reactive with the NSP4 peptide antisera and likely are cleavage products (lanes 3 and 4). A background
band at 30 kDa is present in the uninfected negative control (lane 2). (B) To verify that the 26- and 24-kDa bands correspond to the
monoglycosylated and fully glycosylated forms of NSP4, infected and uninfected MDCK cell lysates were endo H digested, separated by
SDS-PAGE, transferred, and blotted with rabbit anti-NSP4150-175. Lanes 1 and 3 correspond to the undigested negative and positive controls,
respectively. Comparison of lanes 3 and 4 shows the effects of endo H treatment, with the fully glycosylated and monoglycosylated bands shifting
to 20 kDa, equivalent to unglycosylated NSP4.
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membranes and there is a significant loss of peptide binding to
cholesterol-depleted SUVs (25, 26). This cholesterol effect on
NSP4-lipid interactions mimics that of the caveolin-1 choles-
terol dependence in that caveolin-1 structure is altered when
cholesterol is removed from cells or from model membranes
(61). Caveolin-1 not only binds cholesterol but preferentially
incorporates into cholesterol-enriched membranes and func-
tions to transport cholesterol between caveolae and internal
organelle membranes (61, 70). One way in which caveolin-1
transports newly synthesized cholesterol from the ER, through
the cytosol, to PM caveolae is via a soluble complex composed
of hsp56, cyclophilin A, cyclophilin 40, and cholesterol (70). In
addition, caveolin-1 has a constitutive, bidirectional transport
cycle from caveolae to the ER, through the ER-Golgi inter-
mediate compartment, to the Golgi, and back to the PM (12,
19, 60). These caveolin-1-dependent cholesterol pathways have
been shown in MDCK (23), human fibroblast (60, 70), NIH
3T3 (70), and MA104 (61) cells. The critical role of caveolin-1
in cholesterol homeostasis is discussed in detail by Hailstones
et al. (23). We now report that NSP4 not only preferentially
interacts with cholesterol-rich membranes but also binds
caveolin-1. We propose that NSP4 may associate with choles-
terol–caveolin-1 complexes and that this interaction may con-
tribute to the transport of NSP4 from the ER to the PM and
allow NSP4 to avoid Golgi glycosylases.
Several studies suggest that RV and NSP4 interact with lipid
rafts during assembly. Sapin et al. (52) showed that mature
RV, VP4, and NSP4 associate with Triton X-100 detergent-
resistant membranes during infection and that VP4 and puri-
fied virions interact with model membranes resembling lipid
rafts. Those authors suggest that VP4 utilizes rafts as a plat-
form for assembly and NSP4 is necessary for the final stages of
RV morphogenesis (52). In a separate study, newly synthesized
RV associates with rafts both in vitro and in vivo during the
replication process; these data indicate that infectious RV is
transported to the cell surface by a raft-dependent pathway
(14). An earlier study corroborates RV transport to the PM for
release by showing vectorial transport and release of RV from
apical membranes that utilizes a nonconventional vesicular
pathway that bypasses the Golgi complex (28). Lipid associa-
tion in viral assembly is not unique to RV in that several
enveloped viruses interact with rafts during viral assembly and
release. For example, assembly and budding of RSV occur at
lipid rafts, where the viral proteins colocalize with caveolin-1
(9). Association of RSV with lipid rafts is likely important in
viral pathogenesis by generating filamentous particles and pro-
moting syncytium formation (38). Additional viruses, such as
measles virus, vesicular stomatitis virus, human immunodefi-
ciency virus type 1, and Ebola virus, are dependent on raft
associations for assembly and budding (10, 13, 37, 42, 73). We
agree with the earlier prediction that the association of NSP4
with caveolin-1 or caveolae may contribute to the final steps of
RV morphogenesis (52).
Caveolae were first recognized as specialized plasmalemmal
microdomains containing a variety of signal transduction mol-
ecules (2, 32, 57). These include G protein-coupled receptors,
G proteins, small GTPases, adenylyl cyclase, and molecules
involved in the regulation of intracellular calcium homeostasis
(20, 21, 31, 62, 63). The long list of signal transduction mole-
cules enriched in caveolae suggests that close association of
multiple interacting molecules to a single microdomain may
actively contribute to cellular responses to specific external
stimuli (59). Given the compartmentalization of specific sig-
naling cascades and modulation of the function of resident
signaling molecules at caveolae (45, 59), it seems reasonable to
speculate that caveolae serve as a site that regulates signal
integration, including that of the PI signaling event initiated by
extracellular NSP4. In addition, caveolae can be either open or
closed at the cell surface, yielding endocytic or exocytic com-
partments (57, 58). One can envision the possibility of exog-
enously added NSP4 interacting with signaling molecules lo-
calized to rafts or caveolae, but there is no evidence that this
occurs.
Localization of the caveolin-1 binding site to enterotoxic resi-
dues 114 to 135 adds to the multitude of functions attributed to
the NSP4 C-terminal region. The VP6, VP4, and tubulin binding
sites map to NSP4 residues 161 to 175, 112 to 148, and 129 to 175,
respectively (Fig. 8). NSP4 residues 95 to 137 correspond to the
oligomerization domain that folds as an amphipathic coiled coil,
and the cleavage site has been localized to aa 112 (5, 8, 68, 77).
Despite these advances, many questions remain. For example,
what is the NSP4 transport pathway, and how is it regulated?
Which of NSP4 residues 114 to 135 are critical to caveolin-1
binding? What are the effects of blocking the NSP4–caveolin-1
interaction on RV replication and disease? Additional studies are
required to elucidate the functional connection between NSP4
FIG. 7. Refinement of the location of the caveolin-1 binding do-
main to NSP4 residues 114 to 135. In vitro binding assays were per-
formed with NSP4 peptides 113 to 149 (A), 114 to 135 (B and D), and
2 to 22 (C) attached to cyanogen bromide-activated Sepharose 4B
beads. MDCK (A, B, and C) and FRT (C and D) cell lysates were
incubated with the immobilized peptide overnight, pelleted, and sub-
jected to Western blot analysis with anti-caveolin-1 antibody. To make
sure that the antibody was reactive in the Western blot assays, MDCK
cell lysates alone were included in each panel (far right lane of each
panel). To ensure the absence of nonspecific binding to the beads,
MDCK cell lysates were reacted with peptide-free Sepharose 4B beads
(lane 1 in panels A and B and lane 2 in panel C). FRT cell lysates were
reacted with beads only (panel C, lane 1) and with both NSP42-22- and
NSP4114-135-bound beads (lane 4 in panel C and lane 2 in panel D,
respectively) and served as an additional negative control. Test lanes
for NSP4 peptide–caveolin-1 binding included lane 2 in panels A, B,
and D and lanes 3 (MDCK cell lysates) and 4 (FRT cell lysates) in
panel C.
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and caveolin-1 and to determine the role(s) of NSP4–caveolin-1
interaction(s) in NSP4 transport and pathogenesis.
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